Latest news

Today, 5:48 PM

Clinical-stage psychedelics biotech Tryp Therapeutics, Inc.

2 minute read

Business & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patients

Today, 5:48 PM

Psychedelics company Tryp Therapeutics Inc.

2 minute read

Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?

Today, 5:48 PM

Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP.

3 minute read

Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma

Today, 5:48 PM

Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options

DMTTF

5 minute read

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

Today, 5:48 PM

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

CSE:ENBI

2 minute read

Clinical Trials Of Psilocybin Treatment For Overeating Disorder Are Ready, Here’s What Results Show So Far

Today, 5:48 PM

Tryp Therapeutics Inc. (OTCQB: TRYPF) is a clinical-stage biotech company focused on developing psilocybin-based compounds for ill-treated diseases.

3 minute read

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

Today, 5:48 PM

In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its success on the regulation and approval of scheduled psychoactive substances for mental health and other health indications.

ATAI

5 minute read

Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward

Today, 5:48 PM

The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.

ATAI

1 minute read

Could Magic Mushrooms Be A Solution For Overeating? New Clinical Trial Intends To Find Out

Today, 5:48 PM

Psilocybin, the active ingredient in “magic mushrooms,” could be part of the solution for people struggling with binge eating disorder, a condition characterized by recurring episodes of eating large quantities of food and feeling unable to stop.